Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). (Q46136299)
Jump to navigation
Jump to search
scientific article published on 9 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). |
scientific article published on 9 January 2012 |
Statements
1 reference
Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). (English)
1 reference
Michael G Hudgens
1 reference
Kari Syrjänen
1 reference
Joseph Monsonego
1 reference
Laurent Zerat
1 reference
Jean-Claude Zerat
1 reference
Jennifer S Smith
1 reference
9 January 2012
1 reference
1 reference
125
1 reference
1
1 reference
175-180
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference